Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

" An American research team has published extensive research into DNA sequence inversion, a mechanism for bacteria to rapidly ...

The Global Systemic Lupus Erythematosus Treatment Market is valued approximately at USD 2.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.64% over the forecast ...

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT TrialSAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- , (Nasdaq: TVTX) ...

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic has granted temporary marketing ...

The primary objective is to evaluate the safety of CLN-978 for the treatment of active moderate to severe SLE, with secondary ...

The bacterial vaccine proved to be particularly more efficacious than peptide-based therapeutic cancer vaccines that have ...

People living with HIV who need a kidney can rest assured that outcomes are similar whether their kidney donor was also ...

The infectious bursal disease virus (IBDV) causes a major immunosuppressive disease in chickens, leading to economic problems ...

Researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.